We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+13.5%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$104B
AUM Growth
+$5.37B
(+5.5%)
Cap. Flow
-$4.4B
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
23.25%
Holding
3,207
New
74
Increased
1,562
Reduced
1,216
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$249M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$127M |
| 3 |
Broadcom
AVGO
|
+$60.3M |
| 4 |
UBS Group
UBS
|
+$56.9M |
| 5 |
Chubb
CB
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprott Uranium Miners ETF
URNM
|
+$305M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$210M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$152M |
| 4 |
Vale
VALE
|
+$136M |
| 5 |
VMW
VMware, Inc
VMW
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.77% |
| 2 | Financials | 15.13% |
| 3 | Healthcare | 14.14% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Aclaris Therapeutics
ACRS
$851M
| $142K | ﹤0.01% |
135,629
+36,522
| +37% | +$111K |
|
2902
Similarweb
SMWB
$646M
| $141K | ﹤0.01% |
26,536
+11,449
| +76% | +$60K |
|
2903
Microvast
MVST
$261M
| $140K | ﹤0.01% |
100,050
-11,449
| -10% | -$15.4K |
|
2904
NextNav
NN
$2.05B
| $139K | ﹤0.01% |
+31,215
| New | +$141K |
|
|
MURA
2905
DELISTED
Mural Oncology
MURA
| $135K | ﹤0.01% |
+22,758
| New | +$91.5K |
|
2906
Granite Ridge Resources
GRNT
$615M
| $134K | ﹤0.01% |
22,292
| – | – |
|
|
CMRX
2907
DELISTED
Chimerix, Inc.
CMRX
| $129K | ﹤0.01% |
134,000
-65,200
| -33% | -$63.1K |
|
2908
BlackRock MuniYield New York Quality Fund
MYN
$374M
| $126K | ﹤0.01% |
12,200
| – | – |
|
|
FIRY
2909
Firy Inc
FIRY
$156M
| $126K | ﹤0.01% |
20,128
-3,305
| -14% | -$18.5K |
|
|
PNF
2910
DELISTED
PIMCO New York Municipal Income Fund
PNF
| $122K | ﹤0.01% |
15,500
| – | – |
|
2911
NET Power
NPWR
$133M
| $121K | ﹤0.01% |
+11,936
| New | +$143K |
|
2912
LivePerson
LPSN
$27.3M
| $119K | ﹤0.01% |
2,094
-5,939
| -74% | -$273K |
|
2913
Scilex Holding
SCLX
$48.8M
| $115K | ﹤0.01% |
1,609
| – | – |
|
2914
Monte Rosa Therapeutics
GLUE
$1.33B
| $113K | ﹤0.01% |
20,000
-45,353
| -69% | -$178K |
|
2915
1stdibs.com
DIBS
$175M
| $109K | ﹤0.01% |
23,361
-11,446
| -33% | -$48.3K |
|
|
VTYX
2916
DELISTED
Ventyx Biosciences
VTYX
| $108K | ﹤0.01% |
43,918
+5,221
| +13% | +$49.6K |
|
2917
Hallador Energy
HNRG
$698M
| $108K | ﹤0.01% |
+12,257
| New | +$155K |
|
2918
Erasca
ERAS
$6.34B
| $105K | ﹤0.01% |
49,371
+7,326
| +17% | +$15.4K |
|
2919
American Well
AMWL
$220M
| $97.6K | ﹤0.01% |
3,274
-10,316
| -76% | -$253K |
|
|
BLUE
2920
DELISTED
bluebird bio
BLUE
| $97.5K | ﹤0.01% |
3,532
-85,702
| -96% | -$5.23M |
|
2921
Absci
ABSI
$1.41B
| $92.1K | ﹤0.01% |
21,920
-1,025
| -4% | -$1.9K |
|
|
CRDL
2922
Cardiol Therapeutics
CRDL
$157M
| $88K | ﹤0.01% |
80,000
+30,000
| +60% | +$25.5K |
|
|
QVCGA
2923
DELISTED
QVC Group Inc Series A
QVCGA
| $85.9K | ﹤0.01% |
1,962
-7,583
| -79% | -$260K |
|
2924
CS Disco
LAW
$278M
| $84.4K | ﹤0.01% |
11,119
-4,371
| -28% | -$27.6K |
|
|
TIGR
2925
UP Fintech Holding
TIGR
$847M
| $73.8K | ﹤0.01% |
16,703
| – | – |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2023 Portfolio in Review
As of Q4 2023, Credit Suisse held 3,207 positions worth $104B, up 5.5% from $98.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Credit Suisse withdrew a net $4.4B in Q4 2023, closing 156 positions and reducing 1,216 holdings. Its most notable exit was Sprott Uranium Miners ETF, an estimated $305M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Credit Suisse opened a new position in Veralto worth $31.3M.
- Credit Suisse's largest Q4 2023 buy was Veralto: 380,178 shares worth $31.3M.
- Credit Suisse added most to iShares Russell 2000 ETF in Q4 2023, an estimated $249M increase.
- Credit Suisse's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $210M.
- Credit Suisse fully exited Sprott Uranium Miners ETF in Q4 2023, selling an estimated $305M.
- Credit Suisse's ten largest holdings make up 23% of its $104B portfolio in Q4 2023.
- Credit Suisse opened 74 new positions and closed 156 in Q4 2023.
- Credit Suisse's portfolio value rose 5.5% quarter-over-quarter to $104B.
Based on Credit Suisse's 13F filing for Q4 2023, filed 8 Feb 2024.